RCT Trademark

Trademark Overview

On Tuesday, January 3, 2017, a trademark application was filed for RCT with the United States Patent and Trademark Office. The USPTO has given the RCT trademark a serial number of 87287749. The federal status of this trademark filing is REGISTERED as of Tuesday, April 6, 2021. This trademark is owned by Rubius Therapeutics, Inc.. The RCT trademark is filed in the Pharmaceutical Products category with the following description:

Cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders; pharmaceutical preparations of engineered eythroid cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders; engineered erythroid cells for medical or clinical use for the treatment of a variety of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic...
rct

General Information

Serial Number87287749
Word MarkRCT
Filing DateTuesday, January 3, 2017
Status700 - REGISTERED
Status DateTuesday, April 6, 2021
Registration Number6315836
Registration DateTuesday, April 6, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 28, 2017

Trademark Statements

Goods and ServicesCells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders; pharmaceutical preparations of engineered eythroid cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders; engineered erythroid cells for medical or clinical use for the treatment of a variety of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, none of the foregoing related chemical research, research services in connection with physics and engineering research, or to photovoltaic installations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 1, 1970
Primary Code005
First Use Anywhere DateTuesday, October 15, 2019
First Use In Commerce DateTuesday, October 15, 2019

Trademark Owner History

Party NameRubius Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
US
Party NameRubius Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
US
Party NameRubius Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
US

Trademark Events

Event DateEvent Description
Thursday, January 12, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 28, 2017ASSIGNED TO EXAMINER
Tuesday, April 4, 2017NON-FINAL ACTION WRITTEN
Tuesday, April 4, 2017NON-FINAL ACTION E-MAILED
Tuesday, April 4, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 29, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 12, 2017ASSIGNED TO LIE
Monday, October 16, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 16, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 20, 2017EXAMINERS AMENDMENT -WRITTEN
Friday, October 20, 2017EXAMINERS AMENDMENT E-MAILED
Friday, October 20, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 20, 2017EXAMINER'S AMENDMENT ENTERED
Friday, October 20, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 26, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 28, 2017PUBLISHED FOR OPPOSITION
Tuesday, November 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 23, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 2, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 2, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 20, 2018SOU TEAS EXTENSION RECEIVED
Friday, July 20, 2018SOU EXTENSION 1 FILED
Friday, July 20, 2018SOU EXTENSION 1 GRANTED
Tuesday, July 24, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 23, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, January 23, 2019SOU EXTENSION 2 FILED
Wednesday, January 23, 2019SOU EXTENSION 2 GRANTED
Friday, January 25, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 6, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 6, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 23, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, July 23, 2019SOU EXTENSION 3 FILED
Tuesday, July 23, 2019SOU EXTENSION 3 GRANTED
Thursday, July 25, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 23, 2020TEAS STATEMENT OF USE RECEIVED
Thursday, January 23, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, January 28, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 23, 2020SOU EXTENSION 4 FILED
Tuesday, January 28, 2020SOU EXTENSION 4 GRANTED
Thursday, January 23, 2020USE AMENDMENT FILED
Tuesday, January 28, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 13, 2020SU - NON-FINAL ACTION - WRITTEN
Thursday, February 13, 2020NON-FINAL ACTION E-MAILED
Thursday, February 13, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 2, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, September 3, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, September 8, 2020REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
Thursday, August 13, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 13, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 9, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 11, 2020NOTICE OF REINSTATEMENT E-MAILED
Wednesday, September 30, 2020SU - FINAL REFUSAL - WRITTEN
Wednesday, September 30, 2020FINAL REFUSAL E-MAILED
Wednesday, September 30, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, February 18, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, February 18, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 19, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 2, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, March 3, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 6, 2021REGISTERED-PRINCIPAL REGISTER
Monday, April 6, 2026COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

diseases disorders variety genetic cancer cells metabolic namely autoimmune inflammatory